Search Results
8 items found:
-
Technologies - TREATMENT OF ARDS ASSOCIATED WITH COVID-19
This project, is a collaboration of Prof. Yoram Weiss from Hadassah, Prof. Yechezkel Barenholz from HUJI and Prof. Goloubinoff from the University of Lausanne (Switzerland), aiming to treat Acute Respiratory...Researcher/s: Prof. Yoram Weiss -
Technologies - TARGETING NEUTROPHILS AS A THERAPY FOR SEVERE COVID-19 INFECTION
Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19 infection is a rapidly deteriorating condition where components of the immune system react excessively and cause severe lung tissue damage,...Researcher/s: Dr. Zvi Fridlender -
Technologies - HIGH-THROUGHPUT TEST FOR SARS-COVID-2 VIRUS IN PATIENT SAMPLES
The current test for SARS-CoV-2 virus requires several laborious steps as-well-as unique reagents that are at high demand these days. This project of Prof. Dana Wolf, in collaboration with Nir Fridman...Researcher/s: Prof. Dana Wolf -
Technologies - REPURPOSING OF FDA-APPROVED DRUGS FOR INHIBITING THE INFLAMMATORY PROCESS ASSOCIATED WITH CORONA VIRUS INFECTION
Prof. Amnon Peled and his team have screened 1322 FDA-approved drugs for their ability to treat COVID-19 induced Pneumonia using a unique High Throughput Screening assay developed at Prof. Peled#39;s lab....Researcher/s: Prof. Amnon Peled -
Technologies - Non invasive aerosol free PAP ventilation
Non-invasive ventilation is a useful tool in treating chronic to acute respiratory distress syndrome. Current solutions include masks, which often suffer leakage and are difficult to synchronize, and hoods...Researcher/s: Dr. Elchanan Fried -
Technologies - Icough - ACCUMULATIVE BREATH COUGHER
Researcher/s: Dr. Tomer Batash -
Technologies - AN INHALED FORMULATION OF FDA-APPROVED DRUGS FOR TREATMENT OF ARDS
Prof. Rifaat Safadi and his team are developing an inhaled formulation that combines two FDA-approved drugs, which recruit and activate certain types of immune cells in patients with Acute Respiratory...Researcher/s: Prof. Rifaat Safadi -
Units & Labs - The Gutterman Center for Pulmonary Research
The Gutterman Center is a Scientific Leader of IPF and in transnational projects implementing advanced technics for pre-clinical studies in lung research with specific specialties in administration of compounds into the lungs.